Lymph node IL-18 expression in adult-onset Still's disease

Annals of the Rheumatic Diseases

Volumn 68, Issue 3, 2009, Pages 442-443

  Conigliaro, P ^a,c   Priori, R ^a   Bombardieri, M ^b   Alessandri, C ^a   Barone, F ^a,b   Pitzalis, C ^b   McInnas, I B ^c   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; FERRITIN; INTERLEUKIN 18; MONOCLONAL ANTIBODY;

ADULT ONSET STILL DISEASE; CYTOKINE PRODUCTION; FERRITIN BLOOD LEVEL; FOLLICULAR DENDRITIC CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE; LYMPHADENITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME;

ADOLESCENT; ADULT; FEMALE; HUMANS; INTERLEUKIN-18; LYMPH NODES; MALE; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET; YOUNG ADULT;

EID: 61449097657     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.093781     Document Type: Letter

References (10)

1. Gracie JA, Forsey RJ, Chan WL, Gllmour A, Leung BP, Greer MR, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
2. Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003;30:2422-7.
3. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors inthe blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60.
4. Kawaguchi Y, Terajima H, Harigal M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity inadult-onset Still's disease. Arthritis Rheum 2001;44:1716-17.
5. Wei XQ, Leung BP, Arthur HM, McInnes IB, Liew FY. Reduced Incidence and severity of collagen-induced arthritis inmice lacking IL-18. J Immunol 2001;166:517-21.
6. Plater-Zyberk C, Joosten LA, Helsen MM, Sattonnet-Roche P, Siegfried C, Alouani S, et al. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-Induced model of arthritis. J Clin Invest 2001;108:1825-32.
7. Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 2001;44:275-85.
8. Pittoni V, Bombardieri M, Spinelli FR, Scrivo R, Alessandri C, Conti F, et al. Antitumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of Interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis 2002;61:723-5.
9. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004;31:2189-98.
10. Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, et al. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 2004;6:R447-56.